NEW YORK, January 17, 2017 /PRNewswire/ --
http://www.Financialbuzz.com - Investing in small companies is considered to be a risky endeavor. One major issue the small-cap world has to deal with is market inefficiencies. There are very few brokerage firms that put emphasis on small companies, and many small companies have to face this reality. The lack of coverage and low liquidity, provide inefficiencies in the market surface, as institutions often refuse to invest in these risky companies. It is important to remember however, that some small-cap companies have potential to grow, and a strong economy may be of help. As MarketWatch indicated in a recent column, "Higher interest rates in the U.S. means a stronger dollar, which can hurt sales for large companies that rely on exports. But the higher-growth inflationary environment may not blunt small-cap companies, which rely on domestic sales." Solar Integrated Roofing Corp. (OTC: SIRC), OWC Pharmaceutical Research Corporation (OTC: OWCP), PharmaCyte Biotech Inc. (OTC: PMCB), MCig Inc. (OTC: MCIG), Elite Pharmaceuticals Inc. (OTC: ELTP)
Successfully investing in small-cap companies requires extensive due diligence. Investors should look for good management, consistent public filings, and potentially innovative products/services in growing sectors like renewable energy, high-tech, biotechnology, cannabis and others. In addition, digging in the company's financial statements is likely to be beneficial. As MarketWatch has reported, "According to research by fund firm AQR Capital published recently, such firms have outperformed the broader stock market indexes by about five percentage points a year over time."
Solar Integrated Roofing Corp. (OTC: SIRC) is a development-stage company which is focuses on integrated solar and roofing installation. The Company specializes in commercial, residential and industrial properties with an emphasis on acquisitions of similar companies. On January 12th the company signed a lease for new offices in San Dimas, CA. In a press release Solar Integrated Roofing announced that, "the new location will be re-branded to Secure Roofing and Solar sales and installation facility. The new location will encumber the company's latest acquisition of Jure Roofing and Solar. Management believes it is better to stay under one brand as the company expands in Southern California."
"The San Dimas location is approximately 100 miles from the new Poway corporate location, and management is focused on other companies that will help encompass Southern California. Operating in the San Diego area, installing new roofs and providing solar power systems, Solar Integrated Roofing Corp. has lessened the seasonality that you see in other roofing and solar businesses. We find that most solar installations occur in the summer and roofing in the winter. That is distinct from similar businesses in the Midwest and Northeast that have serious downtime when the weather turns bad. Because of that, our business and cash flow is not quite as subject to the swings they experience elsewhere."
Solar Integrated Roofing has also recently announced that it has become an authorized Penntek dealer, adding Penntek's state-of-the-art industrial coatings to the product line SIRC can offer customers. David Massey, CEO of Solar Integrated Roofing Corp., stated, "We are very happy to have this relationship with Penntek. We take the word 'Integrated' in our name seriously, and integrating Penntek's concrete coatings with our roofing systems will help ensure that our customers get the best possible solution to their roofing problems… Concrete is an amazing substance that the human race has used since Roman times to build with, but its versatility comes at a price. Concrete is porous, and it needs to be sealed properly to prevent it from absorbing water, leaking and cracking. The better seal on the concrete, the better the roof. And with Penntek, the seal is as good as it gets."
OWC Pharmaceutical Research Corporation (OTCQB: OWCP) is engaged in the business, through its wholly-owned Israeli subsidiary, One Word Cannabis, that conducts medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, Post-Traumatic Stress Disorder, migraines, and of a unique delivery system. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. OWC Pharmaceutical was engaged in two business activities, with GUMI to commercialize and market the Company's Electromagnetic Percussion Device, and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and diseases.
PharmaCyte Biotech Inc. (OTCQB: PMCB) is a clinical stage biotechnology company that develops therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box®." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. PharmaCyte's therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or cancer-killing form.
MCig Inc. (OTCQB: MCIG) operates as a cannabis cultivation construction company in the United States. The company serves the legal cannabis, hemp, and CBD markets via its lifestyle brands. It designs, develops, engineers, and constructs modular buildings with unique and proprietary elements that assist cannabis growers in the market. The company also offers electronic cigarettes and related products through its online store, mcig.org, as well as through its wholesale, distributor and retail programs. Its segments include Construction, Internet Sales and Wholesale.
Elite Pharmaceuticals Inc. (OTCQB: ELTP) has met with the U.S. Food and Drug Administration for an end-of-review meeting to discuss steps that Elite can take to acquire approval of the company's abuse-deterrent opioid candidate for the management of moderate to severe acute pain drug, SequestOx™. "We are extremely pleased that there is a path forward to seek FDA approval of SequestOx™," said Nasrat Hakim, President and CEO of Elite. "Based on the guidance received from the agency, Elite will begin to execute the proposed plan immediately." Elite Pharmaceuticals is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse-deterrent opioid products as well as niche generic products.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact: email@example.com , +1-877-601-1879